Stay updated on Efficacy of ABT-493/ABT-530 in Japanese Adults: Clinical Trial
Sign up to get notified when there's something new on the Efficacy of ABT-493/ABT-530 in Japanese Adults: Clinical Trial page.

Latest updates to the Efficacy of ABT-493/ABT-530 in Japanese Adults: Clinical Trial page
- Check4 days agoChange DetectedFooter text updated to Revision: v3.3.3; the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe change is a minor revision update from v3.3.1 to v3.3.2 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedPubMed publications note on the study page was clarified to state that publications are automatically filled from PubMed and may not all be related to the study. The page's revision tag was updated to Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding operating status notice from the page; the study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedMinor UI refinements and small text edits were made without altering core study information (eligibility, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Efficacy of ABT-493/ABT-530 in Japanese Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of ABT-493/ABT-530 in Japanese Adults: Clinical Trial page.